This website uses cookies and, in some cases, third-party cookies, to improve user experience. By clicking the button or continuing to use the website you agree to the use of cookies. To find out more, including how to change your settings, see our Cookie Policy.

Teva Pharmaceutical 6.75% 2028-03 USD

Update! New bond issue: Teva Pharmaceutical (NYSE:TEVA) issued new debt notes (USN8540WAB02, N8540WAB0) (144A: US88167AAJ07, 88167AAJ0) for 1.25B USD as of March 7, 2018. Tradable at TRACE OTC as of March 7, 2018. New tranche for 1.25B USD with issue date April 19, 2018. Listed at Stuttgart Stock Exchange as of June 14, 2018.

Teva Pharmaceutical Finance NV operates in the Netherlands as a finance subsidiary of Teva Pharmaceutical Industries Limited, an Israeli multinational pharmaceutical company.

IssuerTeva Pharmaceutical Finance
Stock (Group)NYSE:TEVA
Bond TypeCorporate
CategorySenior
Maturity DateMarch 1, 2028
Residual Duration7 years, 3 months, 5 days
CurrencyUSD (United States Dollar)
Coupon TypeFixed Rate
Coupon (Yearly)6.750%
Coupon FrequencySemiannual
Minimum Lot200,000 USD
Additional Lots1,000 USD
Issue DateMarch 14, 2018
Issued Amount1,250,000,000 USD
Tranche Amount1,250,000,000 USD
Issue Price100.000%
Maturity Price100.000%
Home ExchangeTRACE
Other ExchangesFrankfurt, Berlin, Stuttgart, Munich
IsinUSN8540WAB02
CusipN8540WAB0
Isin 144AUS88167AAJ07 (144A)
Cusip 144A88167AAJ0 (144A)
Temporary IsinUS88167AAK79 (Exchange)
Issue DocumentationIssue Prospectus
IndustryPharmaceuticals
SectorHealth Care
CountryNetherlands
RegionEurope developed


Bonds, Corporate, Health Care, Pharmaceuticals, Europe developed, Netherlands, USD, Fixed Rate, Income


Next Amazon 4.25% 2057-08 USD

investopoli.com